The result is a patch that is small, thin, flexible, and translucent. Menorest delivers 17-beta estradiol into the bloodstream continuously for three to four days, allowing for blood levels of estrogen to be as close as possible to those seen in women before menopause. Menopause normally occurs in women around the age of 50 when blood estrogen levels fall, causing unpleasant symptoms, such as hot flashes, night sweats and vaginal dryness. Rhone-Poulenc Rorer Inc. is a global pharmaceutical company dedicated to improving human health. Menorest has received regulatory approvals in 16 countries to date.
Regulatory approvals are pending in several other countries.
Please contact us with any comments, problems or bugs.